Silver Diamine Fluoride Versus Sodium Fluoride Varnish With Parental Behavior Modification in Arresting Early Childhood Caries

Sponsor
Alexandria University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05761041
Collaborator
Science, Technology & Innovation Funding Authority (STDF) (Other)
140
1
2
12.6
11.1

Study Details

Study Description

Brief Summary

Arresting dental caries using silver diamine fluoride (SDF) has gained attention recently for the management of early childhood caries (ECC). However, black staining is one of its drawbacks. A possible affordable alternative can be Sodium Fluoride (NaF) supported with good oral hygiene induced by parental Motivational Interviewing (MI).

The trial aims to compare the impact of SDF versus NaF supported by MI on lesion activity in preschool children.

Condition or Disease Intervention/Treatment Phase
  • Drug: Sodium Fluoride Varnish (5%)
  • Behavioral: Motivational Interviewing
  • Drug: SDF
Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
140 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Effectiveness of Silver Diamine Fluoride Versus Sodium Fluoride Varnish With Parental Behavior Modification for Arresting Early Childhood Caries: A Randomized Clinical Trial
Actual Study Start Date :
Mar 13, 2022
Anticipated Primary Completion Date :
Mar 1, 2023
Anticipated Study Completion Date :
Apr 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Naf + MI

Sodium Fluoride Varnish 5% (Applied biannually) + two MI sessions: baseline face-to-face session and phone call after 3months.

Drug: Sodium Fluoride Varnish (5%)
Applied at baseline

Behavioral: Motivational Interviewing
Two MI sessions: face-to-face at baseline and phone call at 3 months

Active Comparator: SDF

Silver Diamine fluoride 38% (Applied biannually)

Drug: SDF
Applied bianually

Outcome Measures

Primary Outcome Measures

  1. Caries Arrest [6 months]

    Percentage of arrested carious lesions

Secondary Outcome Measures

  1. Caries Increment [6 months]

    Number of new carious lesions will be assessed using decayed, missing (due to caries), and filled primary tooth surface index (dmfs)

  2. Parental satisfaction [Baseline and 6 months]

    Parents will be asked if application was an easy process, pain free for their child and taste is acceptable. Answers will be on a 5 point Likert scale (Strongly agree, Agree, Neutral , Disagree, Strongly disagree).

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Year to 4 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Children aged ≤ 4 years old.

  2. The presence of at least one active carious lesion on a primary tooth, with scores 3 and higher (according to the International Detection and Assessment System- ICDAS II)

  3. Children whose caregivers have means of communication (mobile phones).

  4. Completion of an informed consent to participate in the study.

Exclusion Criteria:
  1. Children reporting spontaneous or elicited pain from caries or showing any signs of pulpal infection, swelling and/or abscess.

  2. Parental refusal to participate in the study.

  3. Allergy or sensitivity to silver or any of the materials included in the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Alexandria University Alexandria Egypt

Sponsors and Collaborators

  • Alexandria University
  • Science, Technology & Innovation Funding Authority (STDF)

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
randa hassan abdelsamea yassin, Teaching Assistant, Alexandria University
ClinicalTrials.gov Identifier:
NCT05761041
Other Study ID Numbers:
  • 0272 - 07 /2021
First Posted:
Mar 9, 2023
Last Update Posted:
Mar 9, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
Yes
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by randa hassan abdelsamea yassin, Teaching Assistant, Alexandria University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 9, 2023